P2X(7) receptor-nitric oxide interaction mediates apoptosis in mouse immortalized mesangial cells exposed to high glucose

Author(s)

Fernandes, Thamires de Oliveira ; Rodrigues, Adelson Marcal ; Punaro, Giovana Rita ; de Lima, Deyse Yorgos ; Suemitsu Higa, Elisa Mieko

• Document type: Journal article
• Source: J. Bras. Nefrol.; v. 44, n. 2, p. 8-pg., 2022-01-01.

Abstract

Introduction: Diabetes mellitus (DM) is a chronic disease characterized by hyperglycemia that leads to diabetic nephropathy (DN). We showed that P2X(7), a purinergic receptor, was highly expressed in DM; however, when oxidative stress was controlled, renal NO recovered, and the activation of this receptor remained significantly reduced. The aim of this study was to assess the influence of NO on the P2X(7) and apoptosis in mouse immortalized mesangial cells (MiMC) cultured in high glucose (HG) medium. Methods: MiMCs were cultured with DMEM and exposed to normal glucose (NG), mannitol (MA), or HG. Cell viability was assessed by an automated counter. Supernatants were collected for NO quantification, and proteins were extracted for analysis of NO synthases (iNOS and eNOS), caspase-3, and P2X(7). Results: Cell viability remained above 90% in all groups. There was a significant increase in the proliferation of cells in HG compared to MA and NG. NO, iNOS, caspase-3, and P2X(7) were significantly increased in HG compared to NG and MA, with no changes in eNOS. We observed that there was a strong and significant correlation between P2X(7) and NO. Discussion: The main finding was that the production of NO by iNOS was positively correlated with the increase of P2X(7) in MCs under HG conditions, showing that there is a common stimulus between them and that NO interacts with the P2X(7) pathway, contributing to apoptosis in experimental DM. These findings could be relevant to studies of therapeutic targets for the prevention and/or treatment of hyperglycemia-induced kidney damage to delay DN progression. (AU)

• FAPESP's process: 11/12578-1 - Training associated with N-acetylcysteine and modulation of purinergic receptors in the progression of experimental diabetic nephropathy
• Grantee: Elisa Mieko Suemitsu Higa
• Support Opportunities: Regular Research Grants